Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001225176 | SCV001397416 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2019-05-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with FOXP3-related conditions. This variant is present in population databases (rs782377881, ExAC 0.002%). This sequence change affects codon 199 of the FOXP3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FOXP3 protein. |